Oligodendrocytes are neuroglial cells responsible, within the central nervous system, for myelin sheath formation that provides an electric insulation of axons and accelerate the transmission of electrical signals. In order to be able to produce myelin, oligodendrocytes progress through a series of differentiation steps from oligodendrocyte precursor cells to mature oligodendrocytes (migration, increase in morphologic complexity and expression pattern of specific markers), which are modulated by cross talk with other nerve cells. If during the developmental stage any of these mechanisms is affected by toxic or external stimuli it may result into impaired myelination leading to neurological deficits. Such being the case, several approaches have been developed to evaluate how oligodendrocyte development and myelination may be impaired. The present review aims to summarize changes that oligodendrocytes suffer from precursor cells to mature ones, and to describe and discuss the different in vitro models used to evaluate not only oligodendrocyte development (proliferation, migration, differentiation and ability to myelinate), but also their interaction with neurons and other glial cells. First we discuss the temporal oligodendrocyte lineage progression, highlighting the differences between human and rodent, usually used as tissue supply for in vitro cultures. Second we describe how to perform and characterize the different in vitro cultures, as well as the methodologies to evaluate oligodendrocyte functionality in each culture system, discussing their advantages and disadvantages. Finally, we briefly discuss the current status of in vivo models for oligodendrocyte development and myelination.
Introduction
Oligodendrocytes (OL) are the myelinating cells of the central nervous system (CNS). To properly myelinate, OL have to extend many processes that will contact and envelope a stretch of axon. Thus, the progression along the oligodendroglial lineage occurs through a highly regulated program of migration, proliferation, differentiation and myelination. In addition, OL have a high metabolic rate in order to assure myelination. Some studies pointed out that during myelination peak, OL produce three times their weight in myelin and up to 100 times their weight in support membrane per day [1] [2] [3] . These features turn OL into cells highly vulnerable to several damage pathways. To evaluate what is involved in OL development and myelination, the cross talk between these and other nerve cells, or their response to toxic or external stimulus, several approaches can be used. Moreover, the ideal features of a cell culture system for in vitro investigation depend on what questions the system must address. Here, we first address the current view of OL lineage progression, comparing the temporal OL development and myelination in humans vs. rodents. Then, we describe different methodologies to evaluate changes in OL proliferation, migration, differentiation and myelination using pure, co-culture and organotypic slice systems, discussing the advantages and disadvantages of each model. Finally, we compare the use of these in vitro systems with current in vivo models.
Oligodendrocyte lineage progression
During OL development, differentiation steps can be identified according to their migratory capacity, the dramatic increase in morphologic complexity and the expression pattern of specific markers. During maturation, oligodendroglial cells acquire an elaborate morphology and lose their capacity to proliferate and migrate. The majority of authors divide OL maturation stages into four different steps: oligodendrocyte precursor cells (OPC), preoligodendrocytes (or late OPC), immature (or pre-myelinating) OL and mature (or myelinating) OL (Fig. 1) . OPC are proliferative cells, with great migratory capacity and specific expression of platelet-derived growth factor receptor α (PDGF-Rα), ganglioside A2B5, proteoglycan NG2 [4, 5] , polysialic acid-neural cell adhesion molecule [6] and fatty-acid-binding protein (FABP)7 [7] . Although NG2+ progenitors show slightly different morphologies depending on their location in the brain, they are usually characterized by a small polygonal soma and a multipolar tree of fine processes [8] [9] [10] . However, some studies demonstrated that NG2 cells in white matter have a bipolar morphology characteristic of neural precursor cells, with only a few processes that are short in length and emanate from the opposing poles of the cell body [11] . During the differentiation process, OPC give rise to preoligodendrocytes that extend multipolar short processes and start to express OPC markers as well as the sulfatide recognized by the O4 antibody [12] and the GPR17 protein [13] , which persist until the immature OL stage. Upon loss of A2B5 and NG2 markers, immature OL continue to express O4 and begin to express galactocerebroside C [14] . At this point, OL become post-mitotic cells with long ramified branches and are committed to the oligodendroglial lineage [15, 16] . In the final stages of OL development, mature OL extend membranes that form compact enwrapping sheaths around the axons and express, in an orderly manner, myelin proteins (e.g. myelin basic protein [MBP] , proteolipid protein, myelin associated glycoprotein, and finally myelin oligodendrocyte glycoprotein) [17] [18] [19] . Moreover, mature OL also express markers such as MRF/Gm98 [20] , zinc finger protein 488 [21] and FABP5 [7] .
Temporal oligodendrocyte development and myelination -humans vs. rodents
While the proliferation and migration of neurons occur mainly during the prenatal period, the proliferation and migration of glial cells are essentially postnatal processes, with differentiation and maturation taking place throughout childhood. Given these overlapping situations there are several doubts about the temporal extent of each glial cell process during the postnatal period in humans, as well as their intermingled phases.
In humans, only a few studies have assessed the temporal OL development. Four successive OL stages: OPC, preoligodendrocytes, immature OL and mature OL were characterized between 10 and 41 gestational weeks. The first OPC are observed in the forebrain at 10 weeks, higher numbers of OPC are appearing only around 15 weeks, namely in the ganglionic eminences and in the cortical ventricular zone/subventricular zone [22] . Between 18 and 28 weeks, OPC and preoligodendrocytes, identified by NG2 staining, are the most relevant OL stages in parallel with a minor population of immature OL. Between 28 and 40 weeks, a wave of OL differentiation within the periventricular white matter is accompanied by an increase in the number of immature OL and in MBP + myelin sheaths [23, 24] . Around 30 weeks of gestation, a marked increase in O4 + cells displaying a complex multipolar morphology are observed mostly in deeper and milder cerebral white matter, being sparsely distributed in the superficial white matter and not detected in cerebral cortex. The first MBP+ cells are observed between 20 and 28 weeks in subcortical regions, but are only extensively visualized between 36 and 40 weeks, with an increase of myelinated white matter from 1 to 5% of total brain volume [23, 25] .
In rodents, both rat and mouse present the first wave of OPC around embryonic day (E) 9.5 at the telencephalon, namely in the entopeduncular area [26] . Accordingly, it was shown that in E13 mouse, ventral telencephalic regions have a greater capacity to generate OL in vitro than in the corresponding cortical regions [27] . At postnatal day (P)2, both rat and mouse display preoligodendrocytes as the major OL stage in the cerebral white matter with a minor population of immature OL. At P7, the white matter contains more than 80% immature OL that begin to initiate myelination [28] .
In comparison (Fig. 2) , OL lineage progression in cerebral white matter occurs similarly in P2 rodents and around 18-27 weeks of gestation Fig. 1 . Four steps of oligodendrocyte maturation toward oligodendroglial lineage: oligodendrocyte progenitor cells, preoligodendrocytes, immature oligodendrocytes and mature oligodendrocytes. These stages are identifiable according to their increasingly complex morphology, the expression pattern of well-defined markers and their ability to proliferate, migrate and differentiate. CNPase, 2′,3′-cyclic nucleotide 3′-phosphodiesterase; FABP, fatty-acid-binding proteins; GalC, galactocerebroside C; MAG, myelin associated glycoprotein; MBP, myelin basic protein; MOG, myelin oligodendrocyte glycoprotein; MRF, myelin gene regulatory factor, PDGF-Rα, platelet-derived growth factor; PLP, proteolipid protein; PSA-NCAM, polysialic acid-neural cell adhesion molecule; zfp, zinc finger proteins.
in humans, being mostly composed by preoligodendrocytes and few immature OL. Later at P7, the white matter from rodents presents a state of maturation similar to the one observed in humans between 30-36 weeks [24] . Finally, the first MBP + cells are observed around P7 in rodents, becoming increasingly abundant at P14, both in rat and mouse brains [29] [30] [31] , similar to the extent of myelination in many full-term infants [23] .
Concerning myelination, it typically proceeds in a posterior to rostral direction [32] . Some degree of myelination is observed prenatally in humans, so that the peripheral nerves, the pons and the cerebellar peduncles are fairly well myelinated at birth [33] . At 6 months, the genu of corpus callosum is myelinated and, thereafter, between 8 and 12 months, myelination takes place in frontal, parietal and occipital lobes [34] . The volume of white matter increases progressively by approximately 12% from 4 to 22 years of age, and in the prefrontal cortex myelination is completed only in adolescence/early adulthood [35] . In comparison, some studies have revealed that rat myelination appears to begin in the caudal/brainstem regions and to proceed to the forebrain, involving medial regions before the lateral ones, as in humans [32] .
In vitro models to evaluate oligodendrocyte development and myelination
The development of a method to grow OPC from mixed glial cultures [36] has allowed the evaluation of biological processes and mechanisms of cell death in OPC, as well as the mechanisms underlying their differentiation into myelinating OL. However, this in vitro model does not allow the communication between OL and neurons, which is essential for proper myelination. In this context, the co-culture system is very useful, as it allows the maintenance of OL-neuron interaction in the absence of possible confounding effects of other nerve cells. In addition, to evaluate OL development and myelination in conditions very similar to their original environment, ex vivo organotypic slice cultures should be used, since this model preserves the three-dimensional architectural organization that supports cell-cell and cell-matrix interactions.
Oligodendrocyte proliferation model

Oligodendrocyte precursor cells isolation and culture
Primary OPC cultures are isolated from P1 to P2 neonatal rat cortices as previously described by Chen and collaborators [37] with our minor modifications [38] as described in Fig. 3A . In brief, after decapitation the rat brain is collected in Dulbecco's Modified Eagle's Medium (DMEM) (Biochrom AG, Berlin, Germany) and meninges, blood vessels and white matter are removed. After that, cells can be dissociated by mechanical or chemical treatment. For mechanical dissociation, the cortex is homogenized by mechanical fragmentation and the cell suspension passed sequentially through steel screen of 230 and 104 μm pore sizes. For chemical dissociation, cells are incubated with papain (3 U/mL, Worthington, Lakewood, NJ, USA), L-cysteine (0.24 mg/mL, Sigma Chemical Co., St. Louis, MO, USA) and DNase (40 μg/mL, Sigma) for 60 min at 37°C, and then DMEM containing 10% fetal bovine serum (FBS, Biochrom AG) is added to quench the enzyme action. After cellular dissociation, OPC can be isolated by different methods, like shake-off and cell sorting.
First, the most widely used and inexpensive method to isolate OPC is the shake-off technique (Fig. 3A) . Using this approach, dissociated cells are collected by centrifugation at 300 g for 10 min and resuspended in DMEM supplemented with 20% FBS, 1 mM sodium pyruvate (Biochrom AG), 2 mM L-glutamine (Biochrom AG) and 0.5% antibiotic antimycotic (Sigma). Finally, 4 × 10 5 cells/cm 2 are plated on tissue culture flasks and maintained at 37°C in a humidified atmosphere of 5% CO 2 . Culture medium is replaced after 2 days in vitro (DIV) and every 2 days thereafter. After 10 DIV, microglia present on the top of confluent mixed glial cultures are detached by shaking for 1 h at 200 r.p.m. using an orbital shaker. After medium removal, new fresh culture medium is added, and OL at the top of the astrocyte monolayer are detached by shaking for 24 h at 300 r.p.m. Contamination from other glial cells can be removed through filtration with a 30 μm nylon mesh or by differential adhesion in uncoated bacterial dishes during 15 min at 37°C. Another emerging method of OPC isolation is magnetic-activated cell sorting (MACS) that allows OPC separation immediately after brain dissociation [39] . After centrifugation, dissociated brain cells are counted and rat anti-mouse IgM magnetic beads in 10% v/v MACS buffer are added to cells to facilitate the removal of cellular debris and dead cells. After 15 min at 4°C with gentle shaking, cells are resuspended in 5 mL MACS buffer and centrifuged for 5 min. During centrifugation, a MACS column is stepped up on a MACS magnetic stand and equilibrated with 0.5 mL of MACS buffer. After centrifugation, cells are resuspended in 0.5 mL MACS buffer, transferred to the column, and the column is washed four times with 0.5 mL MACS buffer. The initial wash flow through and all subsequent ones are collected in a single tube and centrifuged for 5 min. At this point, bound cell debris and dead cells that remain in the column are discarded. Following centrifugation, the pellet is resuspended in 400 μL of diluted O4 antibody (20% v/v in MACS buffer) and incubated 10 min at 4°C with gentle shaking. Then, the cell suspension is washed two times with 5 mL MACS buffer and centrifuged for 5 min. Taking into account that for every 1 × 10 7 cells, 20 μL MACS beads are mixed with 180 μL MACS buffer, cells are resuspended in an appropriate volume of this mixture, incubated 15 min at 4°C with gentle shaking and centrifuged for 5 min. During centrifugation, another MACS column is equilibrated with 0.5 mL MACS buffer as described before. The pellet is resuspended in 0.5 mL MACS buffer, added to the column and washed four times with 0.5 mL MACS buffer. The column is then removed from the magnet and by positioning above a new tube, bound cells are eluted in 1 mL MACS buffer. A fresh column is quickly equilibrated, the eluted cells added and washed four times After both types of isolation, the final cell suspension is plated at 6 × 10 4 cell/cm 2 on tissue culture plates and maintained in OPC . Culture medium is replaced after 2 DIV and every 2 days thereafter. After 10 DIV, first microglia are detached by 1 h shaking and after oligodendrocytes are detached by 24 h shaking. After isolation, oligodendrocytes are plated in oligodendrocyte precursor cell (OPC) medium and maintained in culture for 6 DIV. At this point, medium is changed every 2 days and at 6 DIV an enriched OPC culture is observed. (B) This culture is constituted mainly by cells with bipolar morphology that express NG2 (84.5%) and a minor fraction is oligodendrocytes in a back stage positive for nestin (4.3%) and preoligodendrocytes positive for A2B5 (10.6%). Only a few cells (0.6%) are astrocytes that stain for glial fibrillary acidic protein (GFAP). Scale bar represents 50 μm. (C) In this model it is possible to incubate OPC with different compounds, like unconjugated bilirubin (UCB), to evaluate and compare changes in OPC viability by TUNEL assay or propidium iodide (PI) or mechanisms underlying OPC demise. By fluorescence it is possible to evaluate individual cell production of reactive oxygen species (ROS) using dihydrorodamine 123 (DHR) dye or mitochondrial dysfunction using Mitotracker® Red dye. Graph bars represent the quantification of apoptosis, necrosis-like cell death, ROS production and mitochondrial dysfunction after UCB treatment. Scale bars represent 20 μm. DMEM, Dulbecco's Modified Eagle's Medium; FBS, fetal bovine serum; FGF-2, fibroblast growth factor 2; GFAP, glial fibrillary acidic protein; PDGF-AA, platelet derived growth factor AA. **P b 0.01 vs. vehicle-treated cells. Adapted from [38] .
medium containing PDGF-AA and FGF-2 to stimulate proliferation and inhibit differentiation. Medium is changed every 2 days and after 6 DIV an enriched OPC culture is obtained.
As shown in Fig. 3B , the majority of the cells present bipolar morphology and express NG2 (84.5%). A minor fraction is OL in a back stage positive for the precursor marker nestin (4.3%) and others are preoligodendrocytes positive for A2B5 (10.6%). Some cells simultaneously stain for NG2 and nestin (cells in a far premature phase) (45.7%), while others stain for NG2 and A2B5 (cells in a rather marginally advanced stage of differentiation than OPC) (38.6%). Only a few cells (0.6%) are glial fibrillary acidic protein (GFAP) positive with typical astrocytic morphology and stain independently of OPC. No MBP or ionized calcium binding adaptor molecule 1 (Iba-1) positive cells are observed, indicating that mature OL and microglia, respectively, are absent in this OPC culture model.
Oligodendrocyte precursor cell viability and functionality assays
This in vitro model of proliferating OPC is useful to evaluate: (i) how certain stimuli can directly disturb the process of OPC proliferation and their survival; and (ii) to clarify the mechanisms underlying OPC demise. In the current review, we present data obtained from our recent studies concerning the role of unconjugated bilirubin (UCB) on OPC survival, differentiation and OL myelination [38, 40, 41] . To evaluate the effect of UCB in OPC survival, at 6 DIV OPC cultures were incubated with 50 μM UCB (Sigma) for 6 h to mimic clinically relevant conditions of jaundice as described [38] . At the end of UCB incubation, adherent OPC cultured on coverslips were rinsed with DMEM and incubated with 75 μM propidium iodide (Sigma) fresh solution to evaluate necrosis-like cell death, or with 50 nM Mitotracker red (Molecular Probes, Eugene, OR, USA) to determine changes in mitochondrial viability. Additionally, another set of OPC was fixed with 4% (w/v) paraformaldehyde in phosphate-buffered saline (PBS, pH 7.4) to evaluate apoptosis-like cell death using TUNEL assay (Roche Molecular Biochemicals, Mannheim, Germany). To evaluate the production of reactive oxygen species (ROS), OPC were incubated with dihydrorhodamine 123 (Sigma) prior to UCB treatment. This non-fluorescent molecule easily crosses cell membranes and is converted by intracellular generated ROS into rhodamine 123, a fluorescent compound that accumulates in mitochondria. As shown in Fig. 3C , treatment with UCB reduced OPC survival either through apoptosis and necrosis-like cell death, involving individual cell mitochondria damage and ROS production. In addition to the methodologies described here, it is also possible to collect cell lysates and evaluate any alterations of the intracellular proteins involved in these or other pathways using Western blot [38] . However, it is known that other glial cells and neurons play an important role on OPC maintenance. To overcome this issue, it is possible to explore the effect of released factors by other nerve cells on OPC survival and proliferation, if we incubate OPC with conditioned medium from another cell type [42, 43] and evaluate the same parameters described above.
Oligodendrocyte precursor cell migration assays
After OPC isolation, their migration can be assayed by different techniques that include Boyden chamber migration assay, agarose drop assay and scratch assay (Fig. 4) .
The Boyden chamber migration assay (Fig. 4A ) is used to evaluate direct migration of OPC in the presence of chemotactic and haptotactic stimuli [44, 45] . In this method, OPC migrate through pores from an upper surface, where cells are plated, to a lower chamber containing either a soluble chemoattractant or a coated lower surface (haptotactic gradient). In this context, isolated OPC are resuspended in DMEM and then 5 × 10 4 cells in 50 μL of DMEM containing 0.5% FBS are seeded in the upper compartment of the Boyden chamber containing an 8 μm diameter polycarbonate membrane with polyvinylpyrrolidone surface treatment. In chemotactic assays, only the medium in the bottom well contains the chemoattractant (directed migration of cells toward regions of higher concentrations), whereas in chemokinetic assays the chemoattractant is added to both lower and upper wells of the chamber, thereby eliminating a chemical gradient (stimulation of increased random cell motility). Commonly used OPC chemoattractants are PDGF and FGF [45, 46] . In haptotactic assays, no chemoattractants are added, but the lower surface of the membrane and the pores are coated with known matrix substrates (i.e., laminin, fibronectin). To assay the role of a specific stimulus on OPC migration, the studied molecules are added to the upper well chamber and OPC allowed to migrate for 6 h to 24 h at 37°C in 5% CO 2 . Membranes are removed from the Boyden chamber, fixed and non-migrated cells from the upper surface of the membrane are discharged by gentle scraping and rinsing. Remaining migratory cells are stained with Giemsa and the number of migrated cells counted. As an example, to assay the role of UCB on OPC migration, cells were plated in the upper compartment of the Boyden chamber in the presence of either 50 μM UCB (chemotaxis) or UCB plus 10 ng/mL FGF (chemokinesis) and allowed to migrate for 24 h to the lower compartment containing FGF (10 ng/mL). As shown in Fig. 4D , both OPC chemokinesis and chemotaxis were remarkably reduced following UCB treatment, the chemotaxis being the most affected one. As advantages, this is a quick assay, with significant migration often being seen within a short time period. Moreover, as the volume required for each well is very small, the cost of experiments involving growth factors or blocking molecules is reduced when compared with other migration assays. Although counting the migrated cells is labor-intensive methodology, it is a precise and objective method. The major disadvantage of this method is the need for a large number of cells, which may represent problems when primary cultures are being used.
In agarose drop assay [46] , OPC migration from a small drop is driven by the high concentration of cells in the agarose drop and the innate motility of cells (Fig. 4B) , allowing the evaluation of chemokinesis or random migration in the presence of different stimuli. In order to perform this assay, isolated OPC are resuspended at a density of 5 × 10 7 cells/mL in Sato media [4 mM L-glutamine, 16 μg/mL putrescine (Sigma), 400 μg/mL triiodothyronine (Sigma), 400 μg/mL thyroxine, 6.2 ng/mL progesterone (Sigma), 5 ng/mL sodium selenite, 100 μg/mL bovine serum albumin, 5 μg/mL insulin, 50 μg/mL holo-transferrin (Sigma) in DMEM] supplemented with 10% FBS and 0.3% low-melting point agarose maintained at 37°C to prevent hardening. Then 1.5 μL drops of this suspension are plated at the center of coated wells (24-well tissue culture plate) and maintained at 4°C for 15 min for the hardening of agarose. After cooling, 50 μL SATO medium is carefully added around the drop and 2 h after, the remaining 450 μl is added down the side of the well. The agent of interest can be added immediately with the medium or 24 h later, in order to evaluate its role on OPC ability to exit from the agarose drop or to migrate, respectively. Cell migration is measured daily for 1 to 6 DIV using a phase contrast microscope with calibrated graticule. Cells migrate out to form a uniform corona around the drop and the distance between the edge of the drop and the leading edge of migrating cells within the corona is measured. The results can be expressed as a distribution curve by measuring the number of cells at different distances from the edge of the agarose drop. In this assay, as cells are maintained in culture for several days aphidicolin (20 μl/mL), which inhibits DNA replication, can be added to the SATO media to prevent proliferation [47] . As advantages, this assay allows the evaluation of cell migration extension at more time-points without compromising the culture viability. Moreover, it enables the introduction and the removal of inhibitors or blocking antibodies after the start of the assay, thus allowing the reversible nature of blocking agents. Finally, migrating OL morphology on different substrates or under different conditions can also be evaluated. The major disadvantage of agarose drop assay is that it takes several days and during this time OL may synthesize and secreat other factors in addition to the factor of interest that can influence migration.
Finally, the in vitro scratch assay is based on the creation of an artificial gap on a confluent cell monolayer, so called "scratch", and subsequent polarization and migration of the cells on the edge of the gap to close the "scratch" (Fig. 4C) . In this assay, OPC are isolated and plated as described in Section 3.1.1. When OPC reach 70-80% confluence, a wound is made across the cells with a cell scraper. Then cultures are washed with DMEM and kept with SATO medium without growth factors and supplemented with the agent of interest. OPC are allowed to migrate for 24-48 h and the number of OPC that moved across the injury line is counted using a phase contrast microscope. Scratch assay is still a method of choice to analyze cell migration, because it is a simple and inexpensive technique and all the required materials are usual labware, also the experimental conditions can be easily modified for different purposes. Moreover, this assay allows the observation of migrating OL morphology and is particularly suitable to evaluate the regulation of cell migration by interaction with extracellular matrix or other cells, since there is no need to isolate OPC and as a consequence disrupt such interactions. Finally, scratch assay is also compatible with live cell imaging allowing the analysis of intracellular signaling events. However, this method does not replace other well-established methods for chemotaxis, like Boyden chamber assay, as no chemical gradient is established. It is also a relatively time-consuming assay when compared with other methods, since several days (i.e. 10-15 DIV) are needed for the establishment of cell monolayer and then around 24-48 h for cell migration to close the "scratch". Another disadvantage is the relatively large amount of cells and chemicals needed for the assay as it is usually performed in a tissue culture plate.
Oligodendrocyte differentiation model
Oligodendrocyte differentiation culture
Primary OPC are isolated as described in Section 3.1.1 and further cultured for differentiation as described by Syed [48] with our minor modifications [40] . Purified OPC are plated at a density of 2.5 × 10 4 cells/cm 2 in SATO media supplemented with 1% penicillin/ streptomycin, 1% insulin-transferrin-sodium selenite (ITS, Sigma), 0.5% FBS, 10 ng/mL PDGF-AA and 10 ng/mL FGF-2 in order to promote OL adherence in a pro-survival and proliferative environment. After 1 DIV, differentiation is induced by replacing PDGF-AA and FGF-2 by 3% FBS in SATO medium and cells are kept in culture in order to obtain an enriched culture of mature OL (Fig. 5A) . In this system, and without the presence of axons, OPC are able to differentiate and synthesize membrane sheets whose organization is very similar to that of myelin. After 7 DIV, cells in culture are mainly mature OL that express MBP (87.0%) and a minor fraction is NG2+ OPC. 
Oligodendrocyte morphological differentiation analysis
Using this model of OL differentiation, it is possible to evaluate if any compound added during the proliferation or the differentiation stages is able to delay or reduce OL differentiation by analyzing first the number of OPC (NG2+ staining) and mature OL (MBP + staining). As an example, to evaluate if UCB treatment during the proliferation stage affects OL maturation, OPC cultures were incubated with 50 μM UCB during the first 24 h after OPC isolation, and kept in culture in SATO medium until 7 DIV [40] . As shown in Fig. 5B , UCB reduced OPC differentiation in MBP+ cells. Moreover, the present model allows the evaluation of Oligodendrocytes (OL) are isolated from P1 to P2 neonatal rat cortices, cultured in mixed glial culture medium and maintained in culture until 10 days in vitro (DIV). Culture medium is replaced after 2 DIV and every 2 days thereafter. After 10 DIV, first microglia are detached by 1 h shaking and after OL are detached by 24 h shaking. After isolation, OL are plated in proliferation medium during 24 h and at this point medium is changed to differentiation medium and OL are kept in culture. After 18 DIV is observed an enriched mature oligodendrocyte culture, constituted mainly by mature OL that express myelin basic protein (MBP) and only few cells are oligodendrocyte progenitor cells that stain with NG2. (B) Using this model of OL culture is possible to evaluate changes in OL differentiation stages. Graph bars represent the quantification of immature OL (NG2+ staining, red) and mature OL (MBP+ staining, green) from vehicle-and UCB-treated cells at 18 DIV. (C) In this model it is also possible to evaluate changes in OL morphology through the division of mature OL in different stages of morphologic maturity like: (1) OL with poorly branched processes, (2) OL with complex branched processes and (3) OL that partially form membranes. Graph bars represent the quantification of OL in these different stages after 18 DIV in the presence or absence of UCB. (D) As demonstrated in this type of culture it is also possible to isolate a single OL in order to perform Sholl analysis and evaluate changes in OL process branching in vehicle-and UCB-treated cells. Scale bar represents 50 μm. DMEM, Dulbecco's Modified Eagle's Medium; FBS, fetal bovine serum; FGF-2, fibroblast growth factor 2; PDGF-AA, platelet derived growth factor AA. **P b 0.01 vs. vehicle-treated cells. Adapted from [40] .
whether certain molecules may also affect OL characteristic morphological changes during maturation. Indeed, it is possible to categorize the morphology of MBP+ mature OL in several stages of maturation such as: 1) OL with poorly branched processes; 2) OL with complex branched processes; and 3) OL with complex morphology that partially form membranes (Fig. 5C ). In the absence of treatment (vehicle-treated cells), most of the mature OL is in stage 2 (71.0%), some in stage 1 (21.6%) and only a few in stage 3 (7.4%). On the other hand, UCB treatment delayed OL morphological maturation presenting an increased number of stage 1 OL (38.7%) [40] . If an increased population of mature OL in stage 3 is desired, the differentiating OL culture must be kept in culture for more days.
In this type of culture, it is also possible to measure OL diameter and process complexity using Sholl analysis. To perform Sholl analysis, first principal OL processes are outlined using NeuronJ plugin for ImageJ (National Institutes of Health, USA) to exclude adjacent cells and secondary processes. Next, a minimum of 50 MBP + cells are measured for the number of intersections made by branching processes with each successive circle using Sholl analysis plugin for ImageJ. In Fig. 5D , vehicle-and UCB-treated cells are shown in a grid of 8 concentric circles with increasing radius superimposed on OL cell body (starting radius, 10 μm; step size, 10 μm; end, 80 μm) and respective graph with the quantification of the number of intersections of primary processes per radius of Sholl ring. Vehicle-treated cells present a total diameter of around 70 μm and a maximum number of intersections from primary processes at 12-20 μm, while UCB-treated cells show a reduced diameter (b60 μm) and reduced extension of maximum intersections from primary processes (8-16 μm) [40] .
These morphological maturation alterations observed in OL branching and membrane formation can be directly related with changes in the activity of Rho family GTPases that have been described as regulators of cytoskeletal structure [49, 50] . Small GTPases of the Rho family, like cdc42, Rac1 and RhoA, are signaling molecules that regulate the organization of the actin cytoskeleton, microtubule dynamics, cell polarity and membrane trafficking in response to environmental signals [51] . In the CNS, active Rac1 and Cdc42 act as positive regulators of morphological differentiation, inducing process extension and branching, while RhoA acts as a negative regulator to inhibit the process of elongation [52] .
Although in these pure OPC/OL culture systems we can identify the OL-specific effect of a certain stimulus in their differentiation and the mechanisms involved, this type of culture does not allow the analysis of signaling interactions between OL and neurons which are crucial for the myelination event.
Myelinating co-culture model
Oligodendrocyte-neuron co-culture
In order to preserve the physiological relevance of OL-neuron interactions and maintain the accessibility of in vitro cell culture models, usually OL-neuron co-culture system is used, that allows the study of myelination without confounding effects exerted by other nerve cell types. Here, we describe the co-culture model that comprises dorsal root ganglion (DRG) neurons cultured on growth factor-reduced 3D Matrigel (BD Biosciences, Erembodegem, Belgium) and OL from the CNS (Fig. 6A) . This culture system is described according to the method reported by Laursen et al. [53] with our minor modifications [40] . DRG neurons are obtained from E15 rats and dissociated with papain (1.2 U/mL), L-cysteine (0.24 mg/mL) and DNase (40 μg/mL) for 60 min at 37°C. After dissociation, DMEM with 10% FBS is added in order to stop enzyme action and cells are collected by centrifugation at 200 g for 5 min. Finally, 150 μL of cell suspension at a density of 1.5 × 10 5 cells are plated on a 18 mm coverslip coated with poly-D-lysine and growth factor-reduced Matrigel, and cultured for 21 DIV in DMEM supplemented with 10% FBS, 1% penicillin/streptomycin and 100 ng/mL nerve growth factor (Serotec, Raleigh, NC, USA). In order to remove contaminating cells, the culture is pulsed three times for 48 h with 5-fluoro-2′-deoxyuridine (20 μg/mL, Sigma) at 1, 4 and 7 DIV after seeding. Culture media are changed every 2 days and after 21 DIV the medium is replaced by basal media Eagle (Gibco, Life Technologies, Inc., Grand Islands, USA) with 1% ITS, 1% penicillin/streptomycin, 1% glutamax (Gibco), 1% glucose (Sigma) and 0.5% FBS. At this time, purified OPC are seeded onto the neurons at a density of 7.5 × 10 4 per coverslip. Co-cultures are maintained for 15 DIV with media changed every 2-3 DIV. In this system, myelination starts 6 DIV after the addition of OPC and it is possible to observe the formation of the first myelin sheaths around 9 DIV. At 14 DIV, after OPC addition, 36 DIV for global culture, the majority of OPC has diffentiated into mature OL and extensive myelination has occurred. The relationship between neurite density and the percentage of OL forming myelin sheaths provides a robust basis for myelination analysis.
Oligodendrocyte differentiation and myelination analysis
In this model also, it is possible to evaluate changes in OL differentiation stages by staining NG2+ OPC and MBP+ mature OL as described for OL differentiation system. As an example, the co-culture system was treated with 50 μM UCB at 1 DIV, in order to evaluate how UCB may affect the initiation of myelination as previously reported [40] . As observed in Fig. 6B , at 14 DIV of co-culture vehicle-treated cells show an increased number of mature MBP expressing OL (57.4%), while UCBtreated cells show a prevalence of NG2 expressing OPC (60.6%). This model also allows the evaluation of the myelination stage of mature OL, categorizing them in three different stages: (1) cells that only extend processes but do not contact with neurofilaments; (2) cells that establish contact with neurofilaments but do not myelinate; and (3) cells that wrap axons and have at least two internodes connected to the cell body (Fig. 6C) . Once again our example shows that in vehicle-treated cells, the majority of cells are OL wrapping (65.5%) or contacting with axons (22.2%) and the remaining cells are OL in earlier phase extending processes (12.0%). However, UCB-treated cells show a delayed myelination process with increased number of OL in the earlier phase only extending processes (33.6%) and a reduced amount of OL contacting (14.1%) or wrapping (49.8%) the axons. In addition, with this model of myelination it is also possible to access the number of myelinated internodes formed by a single OL and the internode length (Fig. 6D) . Visually an internode is defined as a tube of MBP staining surrounding an axon. In this co-culture model, after 14 DIV of coculture, in vehicle-treated cells each OL is able to myelinate approximately 8 internodes with a mean length of 59.3 μm, while in UCBtreated cells one OL myelinated approximately 4 internodes with a mean length of 34.7 μm.
The myelinating co-culture system described here allows the evaluation of the effect of biomolecules on the myelination process as well as the communication between neurons and OL without the interference of other glial cells. The extensive time to obtain this culture, since DRG neurons must be cultured for 3 weeks in order to survive independently of nerve growth factor, a factor that inhibits myelination [54] , and 2 more weeks to see substantial myelination, may be viewed as a disadvantage. Nevertheless, this system is a relatively robust and flexible model that survives up to 8 weeks after the addition of OL and allows the manipulation of gene expression and signaling in vitro since it uses distinct cells from different sources. In this context, OL obtained by different techniques from different CNS regions, different ages or even from different species can be used in this model because all of them are going to myelinate the DRG neurons. Since OL and DRG neurons are first cultured separately, as described above, both cell types can be manipulated independently prior to co-culture. In addition, DRG neurites in this model extend radially from their somas, facilitating the observation and analysis of myelination when compared with co-cultures with neurons dissociated from CNS that are very difficult to analyze due to its reticular distribution [55, 56] . In other hand, it should be noted that DRG neurons are not real CNS neurons since their cell bodies are located outside the CNS and project into the CNS and peripheral nervous system (PNS). However, previous findings have shownthat myelin internode length in cocultures with OL and DRG neurons is very similar to that observed in mouse frontal cortex [57] . 
Cerebellar slice culture
Although in vitro cultures are very useful and accessible models, their main disadvantage resides in the loss of the three-dimensional structure. As so, with the models described above, it is not possible to maintain the normal structure as well as all cell-cell and cell-matrix interactions present in the brain tissue. To overcome this issue, it is possible to study diverse neurobiological processes using ex vivo brain slice cultures, which preserve the three-dimensional architectural organization that supports all tissue circuits and interactions. Slices are thick brain sections (250-400 μm) that are grown on semiporous membranes and kept at an air-liquid interface, which causes less tissue thinning and allow much simple maintenance and processing [58, 59] . When the main goal is to evaluate changes in myelination, organotypic cerebellar slice cultures are usually used, which allow the evaluation of OL maturation process and myelination in a visually defined region. In fact, myelination in cerebellum occurs postnatally and cerebellar slice cultures from early postnatal animals replicate the in vivo myelination process [60, 61] . Moreover, cerebellum presents the largest fiber tracts in the mammalian brain in specific regions, the white matter tracts [62] , which make it an advantageous and practical model to evaluate myelination.
Cerebellar organotypic slice culture
To perform this model, parasagittal slices are prepared from P7 rat cerebellum, according to the interface culture media (Fig. 7A) . First, brains are removed, cerebellum isolated and 400 μm slices cut using a McIlwain tissue chopper and separated under a magnifier. Then four slices are placed in the upper chamber of each 0.4 μm pore cell culture insert (BD Falcon, Lincoln Park, NJ, USA) and maintained in tissue culture plates containing 1 mL of medium constituted by 50% minimum essential medium Eagle (Sigma), 25% normal horse serum (Gibco), 25% Hank's Balanced Salt Solution (Gibco), 6.5 mg/mL D-glucose, 1% Lglutamine and 0.5% penicillin/streptomycin. Half of medium is changed every day and cultures are kept for 7 DIV. Since rat P7 cerebellar slices are not completely myelinated at time of culture, during in vitro maintenance, OL differentiation occurs until these cells fill the white matter of folia and start myelination. After 7 DIV, the cerebellar slice culture evidences a high degree of myelination, based on the significant number of myelin segments aligned with axons. Although this culture starts with 400 μm slices, their thickness reduces with time in culture and present 3 distinct regions in the Z plane that differ in their cellular composition and appearance: the first 1-5 μm ('top') is where the majority of the myelin, axons, OL, OPC and astrocytes reside; the next 6-23 μm ('middle') have the same composition as the 'top' layer, however at lesser amounts; the last 24-30 μm ('bottom') is mostly devoid of all cellular components except microglia, which are also found throughout other depths of the slice albeit at lower densities. It should be noted that before any treatment slice cultures should be kept for 3 DIV to allow the clearance of debris and the stabilization of cerebellar slices. If the goal is to study the effect of a stimulus on myelin formation the culture should be treated around 3-4 DIV, before myelination is complete, and the system analyzed at 7 DIV. If the purpose is to evaluate the effect of an insult on myelination, or how it can promote demyelination, the slices must be kept for 21 DIV prior to treatment and then analyzed after treatment or during the next 14 DIV, where remyelination usually takes place [63] .
Oligodendrocyte differentiation, myelination and glia reactivity analysis
In this ex vivo model, it is possible to evaluate at 7 DIV the presence of immature OPC, mature OL and myelination, as well as the number of glial cells such as microglia and astrocytes. To perform this type of approach slices are stained for NG2+ immature OL, MBP+ mature OL and neurofilaments to evaluate myelination, as well as for Iba-1 + microglia and GFAP + astrocytes. Then the percentage of the area immunoreactive for each cell type is measured. Briefly, binary masks for each staining are defined using the same cut-off intensity threshold value for each region of interest, which corresponds to each cell immunostained, defined as the minimum intensity due to specific staining above background values. Then the percentage of area is measured automatically using ImageJ software in each cerebellum region. Changes in the percentage of myelinated fibers may be assessed by measure of the superposition of neurofilament staining and MBP staining. As an example, we evaluated the effect of UCB in the de novo myelination [41] . So, 3 DIV cerebellar slices were incubated with UCB during 8 h to mimic an acute condition of hyperbilirubinemia. As depicted in Fig. 7B , after 7 DIV, in vehicle-treated slices, the majority of fibers are myelinated (82.3%), while in UCB-treated slices only 57.6% are co-localized with MBP + segments. In addition, vehicle-treated slices also present a lower area occupied by NG2 + OPC (3.1%) in comparison to UCBtreated ones (7.1%) (Fig. 7C) , corroborating the suitability of this ex vivo system to evaluate changes in OL differentiation stages. Moreover, we also observed that UCB treatment promotes microgliosis and astrogliosis as evidenced by an increased area occupied by Iba1 + microglia (from 17.3% to 27.5%, Fig. 7D ) and GFAP+ astrocytes (from 30.4% to 40.4%, Fig. 7E ), respectively.
This culture system should be used when the purpose of the study is the evaluation of OL development and myelination in conditions very similar to their environment, since the model preserves the tissue architecture and cell-cell interactions. In particular, cerebellar slice culture allows the evaluation of changes in OL lineage progression and myelination, because both OPC and OL are abundant in cerebellum and a high degree of compact myelin is formed with a specific pattern after some time [64] . Indeed, in this specific type of organotypic culture, it is possible to follow the complex series of dramatic morphological and biochemical changes that happen during OL maturation and evaluate the effect of biomolecules or potential therapeutic strategies in each crucial step.
In vitro vs. in vivo models for oligodendrocyte development and myelination
The in vitro and ex vivo models described previously are relatively simple and widely applicable models that have the potential to provide information about OL development and how they can be adversely affected by toxic agents, or to be used as a first approach for therapeutic screening. However, the spatial and temporal signaling present in in vivo models is difficult to recreate in vitro, while the response of the systemic circulation and immune cell infiltration often seen in demyelinating disorders is impossible to determine in cells/tissue cultured on a tissue culture plate. So, as in vitro models cannot recreate the complexity of the in vivo biology, in vivo models will be needed as a final step in pre-clinical studies.
Among the in vivo models, zebrafish are increasingly being used to investigate myelination, since zebrafish and mammalian OL and myelin are homologous. Zebrafish are a very useful model as they present a rapid development, are easily manipulable and are transparent as embryos, which facilitates in vivo imaging of myelination. However, the fast growing of this model makes the timing of screens crucial. Some authors have already demonstrated that in zebrafish, the myelin sheath thickness is regulated according to axonal size during larval development [65] , as it occurs in adult CNS of mammals [66] . Moreover, it was recently shown that although global myelination in the zebrafish continues over time, each individual OL only makes new myelin sheaths during a short period of time following initiation of myelination. However, besides these studies in zebrafish are useful to understand myelination, these data may not be all directly translatable to mammals since zebrafish have a large Mauthner axon that has no equivalent in mammals and the protein structure of the myelin sheath is different (CNS myelin in zebrafish contains myelin protein zero that is only present in the PNS in mammals). On the other hand, some rodent myelin mutants can also be used to evaluate myelination in vivo. In this context, transplantation of OPC into the shiverer mouse brain is a well-established method employed to evaluate not only myelination but also cell replacement in vivo. The shiverer mouse is an autosomal recessive mutant in which there is a large deletion in the mbp gene resulting in the failure to produce all six classic protein isoforms of MBP, causing consequently an extensive CNS demyelination [67] . Thus, any myelin produced by wild-type OPC transplanted into a shiverer CNS can be unambiguously identified by positive staining for MBP.
Other way to accelerate the evaluation of myelination in vivo will be the designing of a transgenic mice in which myelin and neurofilaments are labeled with different fluorescent markers, and that after demyelination, a genetic switch is used so that new myelin sheaths are labeled with a third fluorescent marker.
However, in vivo models when compared with in vitro and ex vivo models are substantially more expensive and time-consuming and force the use of a higher number of animals. Thus to test if a certain compound is toxic or may have a therapeutic potential in what concerns OL differentiation and myelination process, researchers must use an in vitro model as we have described here, and only upon promising results should they move on to the in vivo system.
Conclusions
In vitro models to evaluate OL development and myelination are relatively simple and useful systems for the evaluation of the cytotoxicity of several compounds or the efficacy of therapeutic strategies. Although limited by the absence of brain circuits as well as lack of systemic circulation and in vivo signaling, primary cultures are useful models that allow the assessment of a large number of cell functions and processes. In addition, the more complex systems described here may constitute the first approach to the study of the mechanisms related with changes in myelination and some aspects of cell-cell interaction and their effect in OL development and consequent myelination. These models also have the crucial advantage of reducing the number of animals used in in vivo experiments, since they allow the straightforward identification of the targets of different insults or disorders and the first assay of new proposed drugs in the same culture.
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